Trials / Completed
CompletedNCT03705884
PET/MR Imaging In Patients With Cardiac Sarcoidosis
Molecular Imaging in Cardiovascular Disease Using Hybrid Positron Emission Tomography/Magnetic Resonance Imaging (PET/MR): Cardiac Sarcoidosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Edinburgh · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
PET scanning (positron emission tomography) is a well-established technique used to identify areas of interest within the body. It involves injecting a radioactive tracer which highlights abnormal areas. It has recently been combined with CT (computed tomography) and MRI (magnetic resonance imaging) scanning to more accurately identify abnormalities within the heart. Cardiac sarcoidosis, a condition which causes scarring and inflammation within the heart muscle, is of particular interest. The study makes use of hybrid PET/MR scanning using a designated scanner which enables PET scanning combined with MRI scanning. This will allow imaging of abnormal areas within the heart in this condition alongside treatment regimens in a way which hasn't been done before. If successful, this imaging method will play a key role in diagnosing, quantifying and monitoring these conditions. All participants will undergo PET scanning, where a radioactive tracer is injected into a vein before the scan. The radioactive substance only lasts for a short time and is safe, passed out of the body in urine. The scan will be performed twice; once before treatment and once after treatment has been established. A cohort of healthy volunteers will undergo scanning in exactly the same way to enable us to compare the results with hearts of people who don't have cardiac sarcoidosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 18F-FDG | Hybrid 18F-FDG PET/MR imaging for observational diagnostic purposes. |
| DRUG | Prednisolone | Oral course of Prednisolone for treatment of sarcoidosis (patient cohort) or as control (healthy volunteer cohort) |
Timeline
- Start date
- 2017-10-30
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2018-10-15
- Last updated
- 2024-05-17
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03705884. Inclusion in this directory is not an endorsement.